# Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer

> **NCT00120172** · PHASE2 · TERMINATED · sponsor: **Geriatric Oncology Consortium** · enrollment: 40 (estimated)

## Conditions studied

- Colorectal Cancer
- Neoplasm Metastasis

## Interventions

- **DRUG:** oxaliplatin, capecitabine, bevacizumab

## Key facts

- **NCT ID:** NCT00120172
- **Lead sponsor:** Geriatric Oncology Consortium
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-05
- **Primary completion:** —
- **Final completion:** 2006-06
- **Target enrollment:** 40 (ESTIMATED)
- **Why stopped:** positive results from a larger study with same regimen was released.
- **Last updated:** 2007-11-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00120172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00120172, "Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer". Retrieved via MORVS 2026-11-03 from https://api.morvs.ai/clinical/NCT00120172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*